![[ Visit Client Website ]](images/banner.gif)
METHODS: Clinical evaluations were performed and the following validated surveys were administered to skeletally mature patients undergoing reduction mammaplasty, aged 12-21 years: Short-Form 36v2 (SF-36), Rosenberg Self-Esteem Scale (RSES), Breast-Related Symptoms Questionnaire (BRSQ), and Eating-Attitudes Test-26 (EAT-26). Subjects completed surveys at baseline and postoperatively at 6 months, 1 year, 3 years, 5 years, and 7 years.
RESULTS: A total of 512 subjects were included (mean age was 17.8 years). Less than one-third of subjects experienced at least one complication, most commonly: hypertrophic scarring, persistent altered breast or nipple sensation, keloid formation, and wound dehiscence. Complication rates did not vary by BMI category, age, or amount of tissue resected. Patients demonstrated significant postoperative improvements in all SF-36 domains (physical functioning, role-physical, general health, bodily pain, vitality, social functioning, role-emotional, and mental health), and on the RSES, BRSQ, and EAT-26. HRQoL outcomes largely did not vary by complication status.
CONCLUSION: Although major complications following reduction mammaplasty are rare in adolescents, minor complications are common. Complication rates in this sample did not vary by age, BMI, or resection mass. When complications occurred, patients experienced significant postoperative HRQoL gains, comparable to patients without complications. Providers should be aware of the benefits reduction mammaplasty can provide younger macromastia patients, regardless of complication status.